3 results
DDAVP treatment combined with FVIII clotting factor concentrates in patients with mild hemophilia A.
Primary objectives:To assess the proportion of non-severe hemophilia A patients within FVIII target levels with the DDAVP and FVIII concentrate combination treatment in the first 72 hours after the start of combination treatment, without adding off-…
Approved WMOPending
The aim of this study is to determine whether the alleged positive effects of ESG on acute surgical wounds as well as ESG effects on chronic wounds are attributable to this intervention.
Approved WMOCompleted
The primary study objective is the assessment of changes in the stress exhibited by patients using the SAM solution versus those in the control group until the surgical procedure.